{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T06:13:55Z","timestamp":1776147235620,"version":"3.50.1"},"reference-count":4,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Drug Saf. Regul."],"DOI":"10.3389\/fdsfr.2026.1824880","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T05:39:19Z","timestamp":1776145159000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Editorial: Pandemic preparedness in vaccine safety and regulation"],"prefix":"10.3389","volume":"6","author":[{"given":"Manal M.","family":"Younus","sequence":"first","affiliation":[{"name":"Iraqi Pharmacovigilance Centre, Ministry of Health","place":["Baghdad, Iraq"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"van Hunsel","sequence":"additional","affiliation":[{"name":"Netherlands Pharmacovigilance Centre Lareb","place":["sHertogenbosch, Netherlands"]},{"name":"Department of PharmacoTherapy, Epidemiology and Economics, Groningen Research Institute of Pharmacy (GRIP), University of Groningen","place":["Groningen, Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.7573\/dic.2020-12-2","article-title":"The race to a COVID-19 vaccine: opportunities and challenges in development and distribution","volume":"10","author":"Burgos","year":"2021","journal-title":"Drugs Context"},{"key":"B2","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1152\/physiolgenomics.00089.2020","article-title":"The COVID-19 pandemic: a global health crisis","volume":"52","author":"Pollard","year":"2020","journal-title":"Physiol. Genomics"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e1544","DOI":"10.1002\/hsr2.1544","article-title":"The WHO has declared the end of pandemic phase of COVID-19: way to come back in the normal life","volume":"6","author":"Sarker","year":"2023","journal-title":"Health Sci. Rep."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1644680","DOI":"10.3389\/fdsfr.2025.1644680","article-title":"A national pharmacovigilance centre perspective on pandemic preparedness - lessons learned from the COVID-19 pandemic","volume":"5","author":"van Hunsel","year":"2025","journal-title":"Front. Drug Saf. Regul."}],"container-title":["Frontiers in Drug Safety and Regulation"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fdsfr.2026.1824880\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T05:39:24Z","timestamp":1776145164000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fdsfr.2026.1824880\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":4,"alternative-id":["10.3389\/fdsfr.2026.1824880"],"URL":"https:\/\/doi.org\/10.3389\/fdsfr.2026.1824880","relation":{},"ISSN":["2674-0869"],"issn-type":[{"value":"2674-0869","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]},"article-number":"1824880"}}